Drug-Associated Rhabdomyolysis in the FDA Adverse Event Reporting System (FAERS): A Disproportionality Analysis

Name: Drug-Associated Rhabdomyolysis in the FDA Adverse Event Reporting System (FAERS): A Disproportionality Analysis
Uploaded: 2026-10-21T19:59:28.822846+00:00
Duration: 937 s
Description: Researchers analyzed real-world data from FDA adverse event reports to quantify risks of drug-induced rhabdomyolysis for 54 drugs. They used advanced statistical methods to find significant risk signals, identified a major gap in drug labeling, and created a three-tiered risk stratification model. This provides a data-driven framework for improving prescribing safety and regulatory action.

Researchers analyzed real-world data from FDA adverse event reports to quantify risks of drug-induced rhabdomyolysis for 54 drugs. They used advanced statistical methods to find significant risk signals, identified a major gap in drug labeling, and created a three-tiered risk stratification model. This provides a data-driven framework for improving prescribing safety and regulatory action.

Open the full episode